Fostamatinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Fostamatinib is used to treat thrombocytopenia (less than normal number of platelets) in adults with chronic immune thrombocytopenia (ITP; an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood) who were not helped with another treatment.Fostamatinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Fostamatinib Nitroso Impurity 1 CAS NO:NA chemically represented as (6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate. Synchemia is the leading manufacturing and exporter of Fostamatinib Nitroso Impurity 1 . We supply Fostamatinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143316 |
| CAS No | NA |
| Mol.F. | C15H16N2O4 |
| Mol.Wt. | 288.3 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143317 |
| CAS No | NA |
| Mol.F. | C5H10N4O |
| Mol.Wt. | 142.16 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143318 |
| CAS No | NA |
| Mol.F. | C7H14N4O |
| Mol.Wt. | 170.22 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143319 |
| CAS No | NA |
| Mol.F. | C15H16BrN3O |
| Mol.Wt. | 334.22 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143320 |
| CAS No | NA |
| Mol.F. | C6H6N2O3 |
| Mol.Wt. | 154,.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143321 |
| CAS No | NA |
| Mol.F. | C8H10N2O4 |
| Mol.Wt. | 198.18 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143322 |
| CAS No | NA |
| Mol.F. | C9H10N2O3 |
| Mol.Wt. | 194.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143323 |
| CAS No | NA |
| Mol.F. | C14H21N3O4 |
| Mol.Wt. | 295.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143324 |
| CAS No | NA |
| Mol.F. | C8H18N2O5 |
| Mol.Wt. | 222.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143325 |
| CAS No | 67856-67-1 |
| Mol.F. | C12H26N2O5 |
| Mol.Wt. | 278.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143326 |
| CAS No | NA |
| Mol.F. | C10H11ClN2O2 |
| Mol.Wt. | 226.66 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143327 |
| CAS No | NA |
| Mol.F. | C11H16N2O3 |
| Mol.Wt. | 224.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143328 |
| CAS No | NA |
| Mol.F. | C21H27N3O4 |
| Mol.Wt. | 385.46 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143329 |
| CAS No | NA |
| Mol.F. | C14H21N3O4 |
| Mol.Wt. | 295.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143330 |
| CAS No | NA |
| Mol.F. | C21H29N3O5 |
| Mol.Wt. | 403.48 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143331 |
| CAS No | NA |
| Mol.F. | C15H20N4O2 |
| Mol.Wt. | 288.35g/mole |
| INV STATUS | CUSTOM SYNTHESIS |